| Product NDC: | 18860-324 | 
| Proprietary Name: | Niravam | 
| Non Proprietary Name: | alprazolam | 
| Active Ingredient(s): | 2 mg/1 & nbsp; alprazolam | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 18860-324 | 
| Labeler Name: | Jazz Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021726 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20050401 | 
| Package NDC: | 18860-324-01 | 
| Package Description: | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-324-01) | 
| NDC Code | 18860-324-01 | 
| Proprietary Name | Niravam | 
| Package Description | 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (18860-324-01) | 
| Product NDC | 18860-324 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | alprazolam | 
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING | 
| Route Name | ORAL | 
| Start Marketing Date | 20050401 | 
| Marketing Category Name | NDA | 
| Labeler Name | Jazz Pharmaceuticals, Inc. | 
| Substance Name | ALPRAZOLAM | 
| Strength Number | 2 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |